The Analgesic Effect of Pericapsular Nerve Group Block With Lateral Femoral Cutaneous Nerve Block and Pericapsular Nerve Group Block With Supra-inguinal Fascia Iliaca Block in Hip Hemiarthroplasty
A Comparative Study Between the Analgesic Effect of Pericapsular Nerve Group Block (PENG) With Lateral Femoral Cutaneous Nerve Block (LFCN) and Pericapsular Nerve Group Block (PENG) With Supra-inguinal Fascia Iliaca Block (SIFIC) in Hip Hemiarthroplasty: a Prospective Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to investigate the efficiency of preoperative and post-operative analgesia by pericapsular nerve group block (PENG) block with supra-inguinal fascia iliaca block (SIFIC) block compared with PENG block with lateral femoral cutaneous nerve block (LFCN) block in ease of giving a sitting position for spinal anesthesia and reducing narcotic consumption during the first 24 hour post-operatively and functional recovary by using the Visual analogue scale (VAS) of pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2024
CompletedFirst Submitted
Initial submission to the registry
August 27, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 2, 2025
May 1, 2025
9 months
August 27, 2024
May 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Degree of pain
Degree of pain will be assessed by visual analogue score (VAS). VAS ranging from 0 to 10, where 0 is no pain and 10 is maximum pain. It will be assessed preoperatively first after the block application then postoperatively, at post anesthesia care unit (PACU) and then 2, 6 ,12 ,18 ,24 hours postoperatively.
24 hours postoperatively
Secondary Outcomes (4)
The ease of giving a sitting position for spinal anesthesia (EOSP)
Intraoperatively
The total dose of nalbuphine consumption
24 hours postoperatively
The number of patients who needed rescue analgesia
24 hours postoperatively
Ablility to walk with support within 24 hours
24 hours postoperatively
Study Arms (2)
Pericapsular nerve group block (PENG) with supra-inguinal fascia iliaca block (SIFIC)
EXPERIMENTALPatients will receive pericapsular nerve group (PENG) block with supra-inguinal fascia iliaca (SIFIC) block.
Pericapsular nerve group block (PENG) with lateral femoral cutaneous nerve block (LFCN)
EXPERIMENTALPatients will receive pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve (LFCN) block.
Interventions
Patients will receive pericapsular nerve group (PENG) block with supra-inguinal fascia iliaca (SIFIC) block.
Patients will receive pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve (LFCN) block.
Eligibility Criteria
You may qualify if:
- Age 40-80 years.
- Sex: Both sexes.
- American Society of Anaesthesiologists (ASA) Physical Status Class I, II, and III.
- Scheduled for hip hemiarthroplasty under general anesthesia.
You may not qualify if:
- Declining to give a written informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
- Psychiatric disorders or narcotic abusers.
- Significant cognitive dysfunction.
- American Society of Anesthesiologists (ASA) Physical Status Class IV.
- Renal insufficiency (to avoid local anesthetic or nalbuphine metabolites adverse effect)
- Opioid abuser patients
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Cairo Governorate, 11591, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Ain Shams University,Egypt
Study Record Dates
First Submitted
August 27, 2024
First Posted
August 29, 2024
Study Start
January 2, 2024
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
May 2, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.